Renaissance Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.75M Sell
340,157
-67,151
-16% -$1.56M 0.36% 81
2026
Q1
$8.38M Buy
407,308
+79,338
+24% +$1.79M 0.35% 90
2025
Q4
$7.78M Buy
+327,970
New +$7.98M 0.31% 82

Other funds holding PRVA

Renaissance Group's PRVA Position: Q2 2026 in Review

Renaissance Group reduced its Privia Health (PRVA) stake by 16% in Q2 2026, selling an estimated $1.56M and leaving 340,157 shares worth $8.75M. The position accounts for 0.36% of the portfolio, ranked #81.

Renaissance Group first reported a position in PRVA in Q4 2025 and has held it in 3 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Renaissance Group held 340,157 shares of Privia Health worth $8.75M as of Q2 2026.
  • Renaissance Group sold 67,151 Privia Health shares in Q2 2026, an estimated $1.56M.
  • Privia Health made up 0.36% of Renaissance Group's portfolio in Q2 2026, its #81 holding.
  • Renaissance Group first reported a position in Privia Health in Q4 2025 and has held it in 3 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.